Stock 9926 AKESO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Relative Strength Chart Akeso, Inc.

Equities

9926

KYG0146B1032

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:07 2024-06-03 am EDT 		5-day change 1st Jan Change
44 HKD 0.00% Intraday chart for Akeso, Inc. +24.29% -5.17%
May. 31 Akeso's Phase 3 Trial for Non-Small Cell Lung Cancer Treatment Meets Primary Endpoint; Shares Rise 15% MT
May. 31 Akeso, Inc. Announces Registration Phase III Clinical Trial, AK112-303 (HARMONi-2) of ivonescimab (AK112, PD-1/VEGF) CI

End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
AKESO, INC.
Bio Therapeutic Drugs
0.00%+24.29%-5.17%+23.25% - 4.87B
Bearish
Bearish
Bearish
  1. Stock Market
  2. Equities
  3. 9926 Stock
  4. Charts Akeso, Inc.
  5. Relative Strength Chart